logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    King, Linda Anne, Dr
    Born in October 1959
    Individual (5 offsprings)
    Officer
    icon of calendar 2025-02-21 ~ now
    OF - Director → CIF 0
  • 2
    Bolanos-garcia, Victor Martin, Dr
    Born in May 1965
    Individual (2 offsprings)
    Officer
    icon of calendar 2022-02-02 ~ now
    OF - Director → CIF 0
    Dr Victor Martin Bolanos-garcia
    Born in May 1965
    Individual (2 offsprings)
    Person with significant control
    icon of calendar 2022-02-02 ~ now
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
Ceased 1
  • Curtis, Natalie Laura, Dr
    Chief Executive Officer born in July 1995
    Individual
    Officer
    icon of calendar 2022-05-01 ~ 2024-10-24
    OF - Director → CIF 0
    Dr Natalie Laura Curtis
    Born in July 1995
    Individual
    Person with significant control
    icon of calendar 2022-05-01 ~ 2024-10-24
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
parent relation
Company in focus

OXFORD TARGET THERAPEUTICS LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Intangible Assets
212,202 GBP2024-07-31
113,734 GBP2023-07-31
Debtors
12,535 GBP2024-07-31
66,844 GBP2023-07-31
Cash at bank and in hand
56,279 GBP2024-07-31
3,647 GBP2023-07-31
Current Assets
68,814 GBP2024-07-31
70,491 GBP2023-07-31
Creditors
Current, Amounts falling due within one year
-78,225 GBP2024-07-31
Net Current Assets/Liabilities
-9,411 GBP2024-07-31
-37,512 GBP2023-07-31
Total Assets Less Current Liabilities
202,791 GBP2024-07-31
76,222 GBP2023-07-31
Equity
Called up share capital
4 GBP2024-07-31
4 GBP2023-07-31
0 GBP2022-02-01
Retained earnings (accumulated losses)
202,787 GBP2024-07-31
76,218 GBP2023-07-31
0 GBP2022-02-01
Equity
202,791 GBP2024-07-31
76,222 GBP2023-07-31
Profit/Loss
Retained earnings (accumulated losses)
126,569 GBP2023-08-01 ~ 2024-07-31
76,218 GBP2022-02-02 ~ 2023-07-31
Profit/Loss
126,569 GBP2023-08-01 ~ 2024-07-31
76,218 GBP2022-02-02 ~ 2023-07-31
Issue of Equity Instruments
Called up share capital
4 GBP2022-02-02 ~ 2023-07-31
Issue of Equity Instruments
4 GBP2022-02-02 ~ 2023-07-31
Average Number of Employees
22023-08-01 ~ 2024-07-31
32022-02-02 ~ 2023-07-31
Intangible Assets - Gross Cost
Development expenditure
212,202 GBP2024-07-31
113,734 GBP2023-07-31
Intangible Assets - Accumulated Amortisation & Impairment
Development expenditure
0 GBP2023-07-31
Intangible Assets
Development expenditure
212,202 GBP2024-07-31
113,734 GBP2023-07-31
Amount of corporation tax that is recoverable
Current
11,406 GBP2024-07-31
12,818 GBP2023-07-31
Other Debtors
Amounts falling due within one year
1,129 GBP2024-07-31
54,026 GBP2023-07-31
Debtors
Current, Amounts falling due within one year
12,535 GBP2024-07-31
Amounts falling due within one year, Current
66,844 GBP2023-07-31
Other Taxation & Social Security Payable
Current
0 GBP2024-07-31
7,271 GBP2023-07-31
Other Creditors
Current
22,250 GBP2024-07-31
47,757 GBP2023-07-31
Creditors
Current
78,225 GBP2024-07-31
108,003 GBP2023-07-31

  • OXFORD TARGET THERAPEUTICS LIMITED
    Info
    Registered number 13886983
    icon of addressBioinnovation Hub, Tonge Building Oxford Brookes University, Gipsy Lane, Headington Campus, Oxford, Oxfordshire OX3 0BP
    PRIVATE LIMITED COMPANY incorporated on 2022-02-02 (4 years). The company status is Active.
    The last date of confirmation statement was made at 2025-05-06
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.